{
  "id": 1552,
  "text": "But up to now there are no RCTs comparing NACT plus surgery versus primary chemoradiotherapy which is considered the standard of care for locally advanced cervical cancer all over the word.Two recently concluded phase III trials ((EORTC 55994) will hopefully delineate the impact of NACT followed by radical surgery versus chemoradiotherapy in women with LACC.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: But up to now there are no RCTs comparing NACT plus surgery versus primary chemoradiotherapy which is considered the standard of care for locally advanced cervical cancer all over the word.Two recently concluded phase III trials ((EORTC 55994) will hopefully delineate the impact of NACT followed by radical surgery versus chemoradiotherapy in women with LACC.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "目前尚没有针对局部晚期宫颈癌的随机对照试验（RCTs）直接比较术前新辅助化疗加手术与被广泛认为是标准治疗的原发性化学放疗。不过，最近有两个已经结束的III期试验（例如EORTC 55994）有望阐明新辅助化疗后进行根治性手术和化学放疗在局部晚期宫颈癌女性中的影响。",
  "query": "目前是否有针对局部晚期宫颈癌的标准治疗方案进行比较的临床试验，这些试验旨在评估术前新辅助化疗加手术与原发性化学放疗的效果？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 目前是否有针对局部晚期宫颈癌的标准治疗方案进行比较的临床试验，这些试验旨在评估术前新辅助化疗加手术与原发性化学放疗的效果？\n\n<reference text>: But up to now there are no RCTs comparing NACT plus surgery versus primary chemoradiotherapy which is considered the standard of care for locally advanced cervical cancer all over the word.Two recently concluded phase III trials ((EORTC 55994) will hopefully delineate the impact of NACT followed by radical surgery versus chemoradiotherapy in women with LACC.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "目前尚没有针对局部晚期宫颈癌的随机对照试验（RCTs）直接比较术前新辅助化疗加手术与被广泛认为是标准治疗的原发性化学放疗。不过，最近有两个已经结束的III期试验（例如EORTC 55994）有望阐明新辅助化疗后进行根治性手术和化学放疗在局部晚期宫颈癌女性中的影响。"
}